Tatiana López del Río
Chief Executive Officer at Nanogap Sub NM Powder SA
Network origin in Tatiana López del Río first degree
Entity | Entity type | Industry | |
---|---|---|---|
Arjuna Therapeutics
Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge.
5
| Holding Company | Medical/Nursing Services | 5 |
Nanogap Sub NM Powder SA
Nanogap Sub NM Powder SA Miscellaneous Commercial ServicesCommercial Services Nanogap Sub NM Powder SA provides research and development of nanotechnology materials. It serves in the medical, electronic and packaging industries. The firm offers atomic quantum clusters and nanoparticle dispersions in a variety of carrier liquids and solutions. The company was founded by Jose Rivas, Tatiana Lopez del Rio, Vazquez Carlos Vazquez and Arturo Lopez Quintelas in 2006 and is headquartered in Ames, Spain.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tatiana López del Río via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BioMotiv LLC
BioMotiv LLC BiotechnologyHealth Technology BioMotiv LLC operates as a research institution in the field of therapeutics. It focuses in disease areas and classes of therapeutics such as small molecules, antibodies, proteins, and nucleotides. The company was founded on September 10, 2012 and is headquartered in Cleveland, OH. | Biotechnology | Director/Board Member | |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Director/Board Member | |
University of Bath | College/University | Undergraduate Degree | |
University of Oxford | College/University | Doctorate Degree | |
University of Cambridge | College/University | Doctorate Degree | |
Illinois State University | College/University | Undergraduate Degree | |
University of San Francisco | College/University | Graduate Degree | |
REVA MEDICAL INC | Medical Specialties | Director/Board Member | |
University College London | College/University | Doctorate Degree | |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California. | Investment Managers | Chief Executive Officer | |
University of Santiago de Compostela | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
EMPOWER INDIA LIMITED | Electronics Distributors | Director/Board Member | |
Radiant Color NV
Radiant Color NV Chemicals: Major DiversifiedProcess Industries Radiant Color NV is engaged in the production and marketing of fluorescent pigments. Its products include dispersions, special color concentrates, and effect colorants. The company was founded in 1966 and is headquartered in Houthalen, Belgium. | Chemicals: Major Diversified | President | |
NanoCentral | Corporate Officer/Principal | ||
Brilliant Group, Inc.
Brilliant Group, Inc. Wholesale DistributorsDistribution Services Brilliant Group, Inc. manufactures fluorescent pigment services. It manufactures daylight fluorescent pigments, colorants, and ink concentrates for the paints, inks, plastics, textiles, stationery, craft, and other markets. The company was founded by Darren Bianchi in 2007 and is headquartered in Richmond, CA. | Wholesale Distributors | Chief Executive Officer | |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member | |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Director/Board Member | |
CdLS Foundation UK & Ireland | Investment Trusts/Mutual Funds | Director/Board Member | |
DJS Antibodies Ltd.
DJS Antibodies Ltd. BiotechnologyHealth Technology DJS Antibodies Ltd. designs and discovers novel therapeutic monoclonal antibodies against G-protein-coupled receptors. The firm conducts discovery against three targets in the fields of oncology, fibrosis and vascular disease. The company was founded by David Colin Conway Llewellyn and Joseph James Illingworth and is headquartered in Bicester, the United Kingdom. | Biotechnology | Chairman | |
Scioto Biosciences, Inc.
Scioto Biosciences, Inc. BiotechnologyHealth Technology Scioto Biosciences, Inc. operates as a preclinical stage company. It develops therapies to transform the delivery of microbiome therapeutics. The firm?s platform enhances probiotics that are used for diabetes, neurological disorders, gastrointestinal health and alternatives to in-feed antibiotics. The company was founded by Joseph P. Trebley, Jim Schulz, Goodman Steve, Lauren O. Bakaletz, Michael Bailey and Gail E. Besner in May 2017 and is headquartered in Indianapolis, IN. | Biotechnology | Director/Board Member | |
HatchBox Bioconsulting LLC
HatchBox Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services HatchBox Bioconsulting LLC provides life science advisory services. | Miscellaneous Commercial Services | Private Equity Investor | |
Alsa Management Services Ltd
Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Investment Officer | |
BioNeex, Inc.
BioNeex, Inc. Packaged SoftwareTechnology Services BioNeex, Inc. is an American company located in Syracuse, NY, that operates as a drug development platform. It was founded by Smbat Rafayelyan and Tigran Rafayelyan. Smbat Rafayelyan has been the CEO since 2018. The company says this about itself: BioNeex is the first R&D open exchange platform in the biopharma industry, facilitating licensing and co-development partnerships for preclinical and clinical-stage drug candidates between biotech, biopharma companies and research institutions. Data posted on the drug candidate marketplace is listed by biotech, biopharma companies, and research institutions, enabling potential licensing and co-development partners as well as investors to contact them directly with one click. | Packaged Software | Director/Board Member | |
Vantage Biosciences Ltd.
Vantage Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Vantage Biosciences Ltd. develops drugs for diabetic eye disease. The British company was founded by Andre Badalyan, Katie Sunnucks, Graeme R. Martin, Alek Safarian. | Pharmaceuticals: Major | Founder |
Statistics
International
United States | 13 |
United Kingdom | 10 |
Spain | 2 |
India | 2 |
Belgium | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 8 |
Finance | 4 |
Distribution Services | 3 |
Health Services | 2 |
Operational
Director/Board Member | 15 |
Founder | 5 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 4 |
Doctorate Degree | 3 |
Most connected contacts
- Stock Market
- Insiders
- Tatiana López del Río
- Company connections